Hans Ivar Robinson

Chief Executive Officer at

Birk Venture AS

59 year

31 connections

Health Technology

Consumer Services

Commercial Services

Profile

Hans Ivar Robinson is the founder of Birk Venture AS, founded in 2010, serving as Managing Director & Chairman since its founding.
Mr. Robinson is the founder of Zelluna Immunotherapy AS, founded in 2016, serving as Non-Executive Officer since 2024.
Current jobs include Chairman at Nextera AS since 2010 and Director at Accession Therapeutics Ltd. Former jobs include Non-Executive Director at Oncoinvent ASA, Director at APIM Therapeutics AS, Director at Circio Holding ASA, Director at Zelluna ASA from 2025 to 2026, Principal at AstraZeneca AS, Vice President-Investor Relations at Pronova BioPharma ASA in 2009, and Principal at Pfizer AS.
Education includes graduate studies at the Norwegian School of Economics & Business Administration.

Hans Ivar Robinson active positions

Companies	Position	Start
Birk Venture AS Birk Venture AS Investment ManagersFinance Birk Venture is an active manager which makes strategic, long-term investments in life science companies in the pharmaceutical, biotechnology, diagnostics, medical devices and instruments and consumer health sectors. Their geographic focus is on Scandinavia. The firm seeks to identify small-sized listed and unlisted start-up companies with the potential to be public within one to two years which have significant growth prospects, a unique technology and significant market potential. They prefer to invest in companies that have an attractive long-term business case, partnering with entrepreneurs and co-investors to fully exploit the market potential offered by the investee company's new technologies. Through board memberships or direct involvement in specific strategic projects, Birk Venture provides investee companies with a range of internal and external resources including management, sales & marketing, business development, licensing, intellectual property and product portfolio management.	Chief Executive Officer	04/02/2010
Nextera AS Nextera AS Miscellaneous Commercial ServicesCommercial Services Provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer	Chairman	31/12/2009
Zelluna Immunotherapy AS Zelluna Immunotherapy AS BiotechnologyHealth Technology Engages in development of off the shelf T-cell receptor natural killer cell therapies	Founder	31/12/2015
Accession Therapeutics Limited Accession Therapeutics Limited BiotechnologyHealth Technology Develops novel immuno-oncology therapeutics	Director/Board Member	-

All active positions of Hans Ivar Robinson

Former positions of Hans Ivar Robinson

Companies	Position	End
Pronova BioPharma ASA Pronova BioPharma ASA Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets omega-3-derived pharmaceuticals	Public Communications Contact	30/11/2009
CIRCIO HOLDING ASA	Director/Board Member	-
Pfizer AS Pfizer AS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines	Corporate Officer/Principal	-
AstraZeneca AS	Corporate Officer/Principal	-

See the detail of Hans Ivar Robinson's experience

Training of Hans Ivar Robinson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hans Ivar Robinson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
AstraZeneca AS
Pronova BioPharma ASA Pronova BioPharma ASA Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets omega-3-derived pharmaceuticals	Health Technology
Norwegian School of Economics & Business Administration Norwegian School of Economics & Business Administration Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nextera AS Nextera AS Miscellaneous Commercial ServicesCommercial Services Provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer	Commercial Services
Pfizer AS Pfizer AS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines	Health Technology
BerGenBio ASA BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers	Health Technology
APIM Therapeutics AS APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology Develops and commercializes novel anti-cancer therapies	Health Technology
Birk Venture AS Birk Venture AS Investment ManagersFinance Birk Venture is an active manager which makes strategic, long-term investments in life science companies in the pharmaceutical, biotechnology, diagnostics, medical devices and instruments and consumer health sectors. Their geographic focus is on Scandinavia. The firm seeks to identify small-sized listed and unlisted start-up companies with the potential to be public within one to two years which have significant growth prospects, a unique technology and significant market potential. They prefer to invest in companies that have an attractive long-term business case, partnering with entrepreneurs and co-investors to fully exploit the market potential offered by the investee company's new technologies. Through board memberships or direct involvement in specific strategic projects, Birk Venture provides investee companies with a range of internal and external resources including management, sales & marketing, business development, licensing, intellectual property and product portfolio management.	Finance
Circio Holding ASA Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines	Health Technology
Zelluna Immunotherapy AS Zelluna Immunotherapy AS BiotechnologyHealth Technology Engages in development of off the shelf T-cell receptor natural killer cell therapies	Health Technology
Accession Therapeutics Limited Accession Therapeutics Limited BiotechnologyHealth Technology Develops novel immuno-oncology therapeutics	Health Technology